96898 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Anti-CSPG4 reagents and methods of treating cancer
#2102Polynucleotides encoding angiopoietin-2 (ang-2) binding polypeptides
#2103Disruption of the WAVE3 protein complex for suppression of invasion and metastasis
#2104Adsorbent for chromatographic separation of proteins
#2105Alpha connexin c-terminal (ACT) peptides and methods of use thereof
#2106NUCLEAR TARGETING SEQUENCES
#2107EML4-ALK FUSION GENE
#2108Method of treating vitiligo using mutant HSP70i
#2109Muteins of a1m lipocalin and method of production therefor
#2110Modulation of liver genes
#2111IMMUNIZING PEPTIDE, METHOD FOR PRODUCING IMMUNIZING PEPTIDE, PHARMACEUTICAL COMPOSITION FOR IMMUNE DISEASE CONTAINING SAME, AND METHOD FOR TREATING IMMUNE DISEASE
#2112Synthetic transcriptional and epigenetic regulators based on engineered, orthogonal zinc finger proteins
#2113Methods for expanding immune cells
#2114ARRDC1-mediated microvesicles (ARMMS) and uses thereof
#2115Efficient non-meiotic allele introgression
#2116Messenger UNA molecules and uses thereof
#2117Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereof
#2118Controlled gene expression methods
#2119Methods and pharmaceutical composition for the treatment and the prevention of neurological phenotype associated with Friedreich ataxia
#2120Development and use of cysteine-labeled fluorescent probes of unbound analytes
#2121BIOMARKER FOR PARKINSON'S DISEASE AND USE THEREOF
#2122Mutant smoothened and methods of using the same
#2123Antibody-mediated transduction of heat shock proteins into living cells
#2124Opsin polypeptides and methods of use thereof
#2125SERUM AMYLOID P DERIVATIVES AND THEIR PREPARATION AND USE
#2126Sampler and method of parameterizing of digital circuits and of non-invasive determination of the concentration of several biomarkers simultaneously and in real time
#2127CANCER INITIATING CELL AND USE THEREOF
#2128Peptides and combination of peptides for use in immunotherapy against various tumors
#2129NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#2130Peptides and combination of peptides for use in immunotherapy against various tumors
#2131Peptides and combination of peptides for use in immunotherapy against various tumors
#2132Compositions and methods for enhancing an immune response
#2133Proteins specific for pyoverdine and pyochelin
#2134Proteins specific for pyoverdine and pyochelin
#2135Methods and compositions for treating and/or preventing a disease or disorder associated with abnormal level and/or activity of the IFP35 family of proteins
#2136SP-B and SP-C peptides, synthetic lung surfactants, and use thereof
#2137Peptides for the treatment of malignant proliferative diseases
#2138DELIVERY OF POLYNUCLEOTIDES USING RECOMBINANT AAV9
#2139Gene and mutations thereof associated with seizure and movement disorders
#2140FUSION PROTEINS AND METHODS THEREOF
#2141COMPOSITIONS AND METHODS FOR THE DETECTION DIAGNOSIS AND THERAPY OF HEMATOLOGICAL MALIGNANCIES
#2142Inhibitors of T-cell activation
#2143Device and method for detecting a target analyte
#2144Peptides and combination of peptides for use in immunotherapy against various tumors
#2145Proteins specific for pyoverdine and pyochelin
#2146Apelin Fusion Proteins and Uses Thereof
#2147Recombinant self-assembling protein comprising target-oriented peptide and use thereof
#2148MCJ agonists and uses therefor
#2149Engineered T cells and uses therefor
#2150CENTRAL NERVOUS SYSTEM TARGETING POLYNUCLEOTIDES
#2151Method for rapid in vitro synthesis of glycoproteins via recombinant production of -glycosylated proteins in prokaryotic cell lysates
#2152Modified DKK2 protein, nucleic acid encoding the same, preparation method thereof, and use thereof
#2153Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins capable of binding angiopoietin-2 (Ang-2) and methods of use thereof
#2154Synthetic promoters for high throughput screening and gene modulation
#2155Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#2156Non-natural consensus albumin binding domains
#2157WISE/SOST NUCLEIC ACID SEQUENCES AND AMINO ACID SEQUENCES
#2158Compositions of active WNT protein
#2159Human Anti-Tau Antibodies
#2160Modified polynucleotides for the production of oncology-related proteins and peptides
#2161Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositions
#2162MULTILAMELLAR LIPID VESICLE COMPOSITIONS INCLUDING A CONJUGATED ANAPLASTIC LYMPHOMA KINASE (ALK) VARIANT AND USES THEREOF
#2163MOLECULAR SENSORS
#2164Mirac proteins
#2165METHODS AND REAGENTS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION
#2166HUMAN NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (HNGAL) MUTEINS THAT BIND HEPCIDIN AND NUCLEIC ACID ENCODING SUCH
#2167Methods to produce rod-derived cone viability factor (RDCVF)
#2168Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
#2169Method of treating cancer with a multiple integrin binding Fc fusion protein
#2170Method for enhancing immunity using ginsenoside F1 as an active ingredient
#2171CEREBLON ISOFORMS AND THEIR USE AS BIOMARKERS FOR THERAPEUTIC TREATMENT
#2172LABELING AND DETECTION OF POST TRANSLATIONALLY MODIFIED PROTEINS
#2173Cytotoxic molecules responsive to intracellular ligands for selective T cell mediated killing
#2174Polypeptide complex of titin-telethonin beta-pleated sheet structure as polypeptide drug carrier, method of using the polypeptide complex, and fusion protein complex thereof
#2175Tumor antigen peptide
#2176Methods for treating and preventing cardiomyopathy with a fusion protein of tafazzin and a cellular permeability peptide
#2177Use of eRF1 mutants in unnatural amino acid incorporation
#2178Optogenetic tool for rapid and reversible clustering of proteins
#2179COMPOSITIONS AND METHODS FOR MODULATING SALM5 AND HVEM
#2180COLON DISEASE TARGETS AND USES THEREOF
#2181Metabolically Stable Apelin Analogs in the Treatment of Disease Mediated by the Apelin Receptor
#2182Class of therapeutic protein based molecules
#2183METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING DISEASES
#2184Long term hematopoietic stem cell specific reporter mouse and uses thereof
#2185COMPANION DIAGNOSTIC TOOL FOR PEPTIDOMIMETIC MACROCYCLES
#2186In vivo production of proteins
#2187AAV-MEDIATED GENE THERAPY FOR NPHP5 LCA-CILIOPATHY
#2188MT-45 IMMUNODETECTION
#2189Nucleic acid constructs and methods for labeling and detecting nucleosomal DNA modifications
#2190Chloroplast Expressing Colostrum or Milk Polypeptides
#2191Methods and compositions for treating hemophilia
#2192Ghrelin splice variant for treating neuronal damage, neurodegenerative disease, parkinsons disease, alzheimers disease, and/or depression
#2193Efficient delivery of therapeutic molecules in vitro and in vivo
#2194Interleukin-13 binding proteins
#2195Tear lipocalin muteins binding IL-4 R alpha
#2196CHIMERIC PROTEIN
#2197Bi-specific fusion proteins
#2198Methods and compositions for delivering interleukin-1 receptor antagonist
#2199Protoxin-II variants and methods of use
#2200PROTEIN SCAFFOLDS FOR ANTIBODY MIMICS AND OTHER BINDING PROTEINS
#2201SYSTEMS AND METHODS FOR DETERMINING THERAPEUTIC UPTAKE AND DOSING
#2202ENGINEERED FUNGI FOR ITACONIC ACID PRODUCTION
#2203Artificial nucleases comprising engineered cleavage half-domains
#2204GDF15 fusion proteins and uses thereof
#2205Efficient delivery of therapeutic molecules to cells of the inner ear
#2206CARTILAGE-BINDING FUSION PROTEINS
#2207Peptides and compositions for treatment of joint damage
#2208NBP158 and uses thereof
#2209Charged Nutritive Fragments, Proteins and Methods
#2210Satiation peptides for weight loss and altered taste sensitivity
#2211PREDICTION MARKER
#2212Ubiquitin variant modulators of SCF E3 ligases and their uses
#2213METHODS AND PRODUCTS FOR INCREASING FRATAXIN LEVELS AND USES THEREOF
#2214Genetic products differentially expressed in tumors and the use thereof
#2215Cytokine-based fusion proteins for treatment of immune disorders
#2216Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
#2217Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same
#2218INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTION
#2219METHODS AND AGENTS FOR CELLUALR REPROGRAMMING
#2220Peptides and combination of peptides for use in immunotherapy against various tumors
#2221Selective PYY compounds and uses thereof
#2222Capping modules for designed ankyrin repeat proteins
#2223Inhibitors of mitochondrial fission and methods of use thereof
#2224EGFR and c-Met fibronectin type III domain binding molecules
#2225Peptides and combination of peptides for use in immunotherapy against various tumors
#2226NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#2227Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#2228SYNTHETIC PEPTIDES
#2229CA125 GENE AND ITS USE FOR DIAGNOSTIC AND THERAPEUTIC INTERVENTIONS
#2230Adeno-associated viral vectors for treating myocilin (MYOC) glaucoma
#2231Artificially engineered protein hydrogels to mimic nucleoporin selective gating
#2232NUCLEIC ACIDS FOR TREATMENT OF PEANUT ALLERGIES
#2233Substances and methods for the use in prevention and/or treatment in Huntington's disease
#2234Antibodies specific for LOX1 and use in treatment of cardiovascular disorders
#2235SIGNATURES AND PCDETERMINANTS ASSOCIATED WITH PROSTATE CANCER AND METHODS OF USE THEREOF
#2236Auto-inducible expression system
#2237Fusion protein, nanoparticle composed of a plurality of monomers of said fusion protein, and uses thereof
#2238Anti-PACAP antibodies and uses thereof
#2239Humanized anti-PACAP antibodies and uses thereof
#2240Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload
#2241Multivalent and monovalent multispecific complexes and their uses
#2242Methods for treatment of stroke or cerebrovascular accidents using an ETreceptor agonist
#2243ISOLATION OF SOLUBLE PROTEINS FROM AGGREGATED CASEIN-CONTAINING MIXTURES
#2244Methods and compositions for generating a mouse
#2245Car expression vector and car-expressing T cells
#2246ANTIBODIES SPECIFIC FOR IL-17A FUSED TO HYALURONAN BINDING PEPTIDE TAGS
#2247Production cell line enhancers
#2248Activation of adaptive immune processes for the treatment of cancers and infectious diseases
#2249Rodents having a humanized TMPRSS gene
#2250Resonance energy transfer assay with cleavage sequence and spacer
#2251Chimeric Receptors with 4-1BB Stimulatory Signaling Domain
#2252MYC NUCLEIC ACIDS AND USES THEREOF
#2253Cancer vaccine compositions and methods of use thereof
#2254Process For Isolation of Plasma or Serum Proteins
#2255Activin type 2 receptor antibodies
#2256BONE MARROW STROMAL CELL DERIVED EXTRACELLULAR MATRIX PROTEIN EXTRACT AND USES THEREOF
#2257Monoclonal antibody, inhibiting the enzymatic activity of vascular endothelial lipase
#2258Nucleic acids, vectors, host cells, and methods for recombinantly producing water-soluble membrane proteins
#2259PROTEIN SCAFFOLDS FOR ANTIBODY MIMICS AND OTHER BINDING PROTEINS
#2260Ubiquitin variant modulators of HECT E3 ligases and their uses
#2261NOVEL PEPTIDE COMPOSITIONS
#2262Therapeutic and research application of PDCL3
#2263Synthetic bi-epitope compound
#2264Method of treating CD155 expressing cancers
#2265Novel Read-Through Fusion Polynucleotides and Polypeptides and Uses Thereof
#2266Compositions and methods for the delivery of oxygen
#2267POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN THE PROCESS OF BONE REMODELING
#2268Humanized monoclonal antibody, inhibiting the enzymatic activity of vascular endothelial lipase
#2269Modified colostrum protein and application thereof
#2270Endoplasmic Reticulum Localization Signals
#2271POLYPEPTIDE EXPRESSED IN THE STRATUM CORNEUM AND USE THEREOF
#2272FGL2 Expressing Regulatory T Cells
#2273Neprilysin as heart failure prognostic marker
#2274Homeobox gene
#2275Promoter and regulatory elements for improved expression of heterologous genes in host cells
#2276Medicament for Atrophy Treatment or Increasing Cell Growth
#2277NUCLEIC ACID CONSTRUCTS INCLUDING A TXNIP PROMOTER FOR THE TREATMENT OF DISEASE
#2278REGULATION OF ENDOGENOUS GENE EXPRESSION IN CELLS USING ZINC FINGER PROTEINS
#2279Method for efficient delivery of therapeutic molecules in vitro and in vivo
#2280STAPLED INTRACELLULAR-TARGETING ANTIMICROBIAL PEPTIDES TO TREAT INFECTION
#2281Cell-free methods of producing vault particles and vault particles resulting therefrom
#2282Methods and tools for detecting interactions in eukaryotic cells using microtubule structures and dynamics
#2283CSN5 polypeptides and uses thereof for screening therapeutic agents
#2284Modulation of the VPS10p-Domain Receptor Family for the Treatment of Mental and Behavioural Disorders
#2285Chimeric antibacterial polypeptides
#2286CYCLIC POLYPEPTIDES FOR THE TREATMENT OF HEART FAILURE
#2287Peptidylic inhibitors of nucleolin (NCL) targeting CAG-repeat RNA toxicity and methods for reducing polyQ-mediated toxicity in polyQ diseases
#2288Method for separating proteins from animal or human plasma, or plants, using a pH gradient method
#2289Pig model for diabetes
#2290Calbindin and BH3 domain chimeric proteins and methods for use
#2291MODIFIED PEPTIDES AND THEIR USE FOR TREATING AUTOIMMUNE DISEASES
#2292Methods for treating cardiovascular dysfunction and improving fluid homeostasis with Elabela peptide hormone
#2293Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation
#2294Application of TRPM8 protein, related peptide fragment and their antibodies
#2295Allergen
#2296NOVEL FUSION PARTNERS FOR THE PURPOSE OF CRYSTALLIZING G-PROTEIN COUPLED RECEPTORS
#2297COMPOSITIONS AND METHODS FOR TREATMENT WITH HEMOPEXIN
#2298INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS 9
#2299Sugar transporters
#2300CONSTANT REGION ANTIBODY FUSION PROTEINS AND COMPOSITIONS THEREOF
#2301Methods for improving cardiac function by administering an antibody that activates APLNR
#2302Composition containing SMAD protein for treatment of autoimmune diseases, a fusion protein comprising SMAD protein, an expression vector and a method for preparing the same
#2303Peptides for the specific binding of RNA targets
#2304Methods of identifying ActRIIB variants
#2305Stabilized influenza hemagglutinin stem region trimers and uses thereof
#2306CONFIGURABLE CLATHRIN LIGHT CHAIN COMPOSITION
#2307Marker sequences for diagnosing and stratifying systemic sclerosis patients
#2308Sulfonated sclerostin, antibodies, epitopes and methods for identification and use therefor
#2309PROCESS OF AFOD AND AFCC AND MANUFACTURING AND PURIFICATION PROCESSES OF PROTEINS
#2310NUCLEOTIDE REPEAT EXPANSION-ASSOCIATED POLYPEPTIDES AND USES THEREOF
#2311CELL-PERMEABLE (ICP)-SOCS3 RECOMBINANT PROTEIN AND USES THEREOF
#2312HCBI, MSBI, MSSI AND CMI SEQUENCES AS AN EARLY MARKER FOR THE FUTURE DEVELOPMENT OF CANCER AND DISEASES OF THE CNS AND AS A TARGET FOR THE TREATMENT AND PREVENTION OF THESE DISEASES
#2313METHODS FOR REPAIRING CARTILAGE DAMAGE
#2314KIF20A epitope peptides for TH1 cells and vaccines containing the same
#2315PERFORIN 2 DEFENSE AGAINST INVASIVE AND MULTIDRUG RESISTANT PATHOGENS
#2316Methods of treating cancer by administering IGF-IR binding molecules
#2317Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereof
#2318E1-MINUS ADENOVIRUSES AND USE THEREOF
#2319Mutant NGAL proteins and uses thereof
#2320Peptide for Protection of Allergic Respiratory Disorders
#2321Peptides and combination of peptides for use in immunotherapy against various cancers
#2322Peptides and combination of peptides for use in immunotherapy against various cancers
#2323Peptides and combination of peptides for use in immunotherapy against various cancers
#2324Peptides and combination of peptides for use in immunotherapy against various cancers
#2325Peptides and combination of peptides for use in immunotherapy against various cancers
#2326Peptides and combination of peptides for use in immunotherapy against various cancers
#2327PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the same
#2328Mutant NGAL proteins and uses thereof
#2329Compositions and methods for increasing the expression and signalling of proteins on cell surfaces
#2330METHODS AND COMPOSITIONS FOR SUPPRESSING RETROVIRUSES
#2331Method of preventing polycystic kidney disease and PKD animal model with exogenous neutrophil gelatinase-associated lipocalin
#2332Internalizing moieties
#2333Multivalent heteromultimer scaffold design and constructs
#2334Antibody to mucin 4 (MUC4) glycopeptide and uses thereof
#2335Oligosaccharide modification and labeling of proteins
#2336Methods for the treatment of cardiovascular fibrosis
#2337Human derived anti-Huntingtin (HTT) antibodies and uses thereof
#2338Chimeric inhibitor molecules of complement activation
#2339Proteins specific for calcitonin gene-related peptide
#2340Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#2341Peptides and combination of peptides for use in immunotherapy against various cancers
#2342Methods to Treat Diseases with Protein, Peptide, Antigen Modification and Hemopurification
#2343METHOD FOR FUSION EXPRESSION OF ION CHANNEL PROTEIN AND TRANSPORT PROTEIN AND PROTEIN FRAGMENT USED THEREFOR
#2344Modification of RNA-related enzymes for enhanced production
#2345Peptides and combination of peptides for use in immunotherapy against various tumors
#2346Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
#2347OPTOGENETIC CONTROL OF REWARD-RELATED BEHAVIORS
#2348Use of endostatin peptides for the treatment of fibrosis
#2349CDK MODULATORS AND METHODS FOR THE TREATMENT OF CANCER
#2350Methods and kits for detecting brain injury
#2351Calcium reporter gene
#2352Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions
#2353EHD2 Antibody and Application Thereof in Preparation of Immunohistochemical Detection Reagent for Breast Cancer
#2354Peptides and combination of peptides for use in immunotherapy against various tumors
#2355Peptides and combination of peptides for use in immunotherapy against various tumors
#2356System utilizing light-activated ion channel protein (VChR1) for optical stimulation of target cells
#2357Modulation of cellular stress using a B-cell oxidative and/or endoplasmic reticulum stress inhibitor and a targeting agent
#2358Vault complexes for cytokine delivery
#2359Fibronectin binding domains with reduced immunogenicity
#2360Mps1 and KNL1 phosphorylation system
#2361Epitope tag and method for detection and/or purification of tagged polypeptides
#2362Antibody, epitope tag and method for detection, capture and/or purification of tagged polypeptides
#2363A Diagnostic Marker For Paget's Disease
#2364METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#2365Natriuretic polypeptides
#2366Pharmaceutical compositions and their use for the treatment of autoimmune disorders
#2367Modified Friedreich ataxia genes and vectors for gene therapy
#2368Peptides for the treatment of neurodegenerative diseases
#2369Composition for preventing or treating fatty liver or insulin resistance syndrome including extracellular domain of delta-like 1 homolog
#2370USING B-CELL-TARGETING ANTIGEN IGG FUSION AS TOLEROGENIC PROTEIN THERAPY FOR TREATING ADVERSE IMMUNE RESPONSES
#2371Peptide, complex of peptide and siRNA and use thereof
#2372Method for the detection of cancer cells by localization of peptides in nucleus as compared to cytoplasm
#2373Method for treating kidney disease with a SLIT2-binding extracellular domain of ROBO2
#2374Neutralizing antibodies and methods of use thereof
#2375Muteins of human lipocalin 2 (Lcn2,hNGAL) with affinity for a given target
#2376Genetically encoded histone reporter allele constructs
#2377Monomeric avidin-like proteins with stable biotin binding ability
#2378Method of genetically altering and producing allergy free cats
#2379Methods of cancer therapy by inhibiting fusion polypeptides comprising fibroblast growth factor receptor 2 (FGFR2) and vinculin (VCL)
#2380Specific-binding polypeptides and uses thereof
#2381Met e 1 tropomyosin variants for use in allergen-specific immunotherapy
#2382Apelin polypeptides
#2383Compositions and methods for targeting nuclear import shuttles and treating inflammatory disorders
#2384Development and use of fluorescent probes of unbound bilirubin
#2385Bi-specific annexin A5/IGF-1 proteins and methods of use thereof to promote regeneration and survival of tissue
#2386HTT repressors and uses thereof
#2387Engineered light-activated anion channel proteins and methods of use thereof
#2388Antibodies to TTR and Methods of Use
#2389Neurotensin-induced tumor formation is regulated by micro RNA 133A-aftiphilin-dependent receptor recycling
#2390Modular antigen transportation molecules and uses thereof in animals
#2391Genetic engineering of macrophages for immunotherapy
#2392Methods of Detecting Alloantibodies Using HLA and Non-HLA Antigens
#2393GITRL-collectin fusion proteins and encoding nucleic acids
#2394GENERATION OF BRAIN AND SPINAL CORD NEURONS, CARDIAC MYOCYTES, RENAL NEPHRONS AND HEPATOCYTES USING REG PEPTIDES, PEPTIDOMIMETICS, SMALL MOLECULES AND STIMULATORY ANTIBODIES TO REG RECEPTOR
#2395TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS
#2396SOLID PHASE PEPTIDE SYNTHESIS METHODS AND ASSOCIATED SYSTEMS
#2397Methods and systems for solid phase peptide synthesis
#2398Methods of delivering a polypeptide molecule to Otx2 target cells using an Otx2 targeting peptide
#2399Binding-induced DNA nanomachines
#2400Method of engineering multi-input signal sensitive T cell for immunotherapy